Analytical Data
-
Gene name
CLTC
- Application
-
Alternative Names
CLTCL2; Hc; CLH17; Clathrin,Heavy Polypeptide-Like 2; Clathrin heavy chain 1; Clathrin heavy chain on chromosome 17
-
Species
Human
-
Source
E. coli
-
Tag
N- His & GST
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q00610
-
Expression Region
Ala2~Pro242
-
Molecular Weight
57kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CLTC, or clathrin, is a crucial protein involved in the endocytic processes of cells, facilitating the internalization of various molecules through the formation of coated vesicles. Recent research has highlighted its role not only in membrane trafficking but also in cellular signaling and the maintenance of cellular homeostasis. The study of CLTC-recombinant proteins has gained momentum due to their potential applications in understanding the mechanisms underlying various diseases, including cancer and neurodegenerative disorders. By expressing and purifying CLTC in recombinant systems, researchers aim to elucidate its structural properties and interaction dynamics with various cellular partners. This approach allows for in-depth investigations into the protein's function, structure-function relationships, and the effects of post-translational modifications. Moreover, CLTC-recombinant proteins serve as valuable tools in drug delivery systems and the development of targeted therapies. Overall, the exploration of CLTC through recombinant technology provides critical insights into cellular processes and paves the way for novel therapeutic strategies.
